IMCD Overview

  • Founded
  • 1995
Founded
  • Status
  • Public
  • Employees
  • 2,991
Employees
  • Stock Symbol
  • IMCD
Stock Symbol
  • Investments
  • 53
  • Share Price
  • $122.86
  • (As of Friday Closing)

IMCD General Information

Description

IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two major categories: life sciences and industrials. Life sciences products include pharmaceuticals, personal-care products, and food and nutrition additives and ingredients. Industrials products include coatings, lubricants, synthesis chemicals, plastics, and detergents for home and commercial use. The company organizes itself into four primary segments based on geography: Europe, Asia-Pacific, other emerging markets, and United States. Most of IMCD's revenue comes from Europe.

Contact Information

Formerly Known As
Internatio, Internatio-Muller (Chemical Distribution)
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Specialty Chemicals
Other Commercial Products
Stock Exchange
AMS
Primary Office
  • P.O. Box 5802
  • 3008 AV Rotterdam
  • Netherlands
+31 010 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IMCD Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$122.86 $121.72 $56.61 - $131.11 $6.99B 56.9M 146K $2.27

IMCD Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 5,478,989 5,038,846 3,827,954 3,647,811
Revenue 2,988,364 3,010,888 2,807,495 2,151,046
EBITDA 269,688 267,764 241,994 182,349
Net Income 119,205 120,907 118,074 87,133
Total Assets 2,468,068 2,450,809 2,229,843 1,984,597
Total Debt 635,746 657,107 551,020 441,245
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IMCD Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IMCD‘s full profile, request access.

Request a free trial

IMCD Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two
Holding Companies
Rotterdam, Netherlands
2,991 As of 2019
00000
0.000 0000-00-00
00000000000 00000

00000000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
00000-0000 000000000
Essen, Germany
00000 As of 0000
00000
00000000000 00000

0000000

it amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
000000000 000000000
Chicago, IL
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IMCD Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Brenntag Formerly PE-Backed Essen, Germany 00000 00000 00000000000 00000
0000000 000000000 Private Equity-Backed Chicago, IL 000 00000 000000000 00000
000000 Corporate Backed or Acquired Rotterdam, Netherlands 000 000000&0
00000000 Private Equity-Backed Harleysville, PA 0000 000000000000
000 000000000 Corporate Backed or Acquired Fort Worth, TX 000 00000 000000&0 00000
You’re viewing 5 of 7 competitors. Get the full list »

IMCD Executive Team (20)

Name Title Board Seat Contact Info
Piet van der Slikke Chief Executive Officer
Marcus Jordan President
Hans Kooijmans Chief Financial Officer
Amit Hirani Managing Director
Didrik Von Porat Managing Director
You’re viewing 5 of 20 executive team members. Get the full list »

IMCD Board Members (5)

Name Representing Role Since
00000 00000 Self Vice Chairman & Chairman, Audit Committee 000 0000
0. 000000000 IMCD Member Of Supervisory Board 000 0000
0. 000 00000 00000 IMCD Board Member 000 0000
0000-0000000 00000 Self Board Member 000 0000
To view IMCD’s complete board members history, request access »

IMCD Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IMCD Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IMCD‘s full profile, request access.

Request a free trial

IMCD Investments & Acquisitions (53)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000 (00000 26-Nov-2020 000000000000000000 Distributors/Wholesale 00000 000000
0000 0000000000000 05-Nov-2020 000000000000000000 Pharmaceuticals 00000000 0000000
000000 0000000000 04-Nov-2020 000000000000000000 Distributors (Healthcare) 0000 000 000 000000
00000-00000 18-Sep-2020 000000000000000000 Distributors/Wholesale 0000 0000000
Siyeza Fine Chem 01-Sep-2020 Merger/Acquisition Other Healthcare Services
You’re viewing 5 of 53 investments and acquisitions. Get the full list »

IMCD Subsidiaries (17)

Company Name Industry Location Founded
Network Nutrition Biotechnology Sydney, Australia 2004
00000 00000000 000 Multi-line Chemicals Mumbai, India 0000
000000000 Distributors/Wholesale Milan, Italy 0000
000000 00000000000 Distributors (Healthcare) Seoul, South Korea 0000
000 000000 Pharmaceuticals Basel, Switzerland 0000
You’re viewing 5 of 17 subsidiaries. Get the full list »

IMCD Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 12-Nov-2012 0000000000 Completed
  • 3 buyers
To view IMCD’s complete exits history, request access »